Skip to main content
TipRanks
Go Ultimate75% OFF

Cerenome (XMP1) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Cerenome has a market cap or net worth of EUR 5.61M. The enterprise value is EUR 13.26M.

Market Cap
EUR 5.61M
Enterprise Value
EUR 13.26M

Share Statistics

Cerenome has 9,776,935 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
9,776,935
Owned by Insiders
1.12%
Owned by Institutions
9.76%

Financial Efficiency

Cerenome’s return on equity (ROE) is -5.60 and return on invested capital (ROIC) is -317.58%.

Return on Equity (ROE)
-5.60
Return on Assets (ROA)
-1.37
Return on Invested Capital (ROIC)
-317.58%
Return on Capital Employed (ROCE)
-3.81
Revenue Per Employee
186.18K
Profits Per Employee
-799.50K
Employee Count
28
Asset Turnover
0.32
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Cerenome is -0.14. Cerenome’s PEG ratio is 0.00.

PE Ratio
-0.14
PS Ratio
1.38
PB Ratio
-5.25
Price to FCF
-0.17
Price to Operating Cash Flow
-0.18
PEG Ratio
0.00

Income Statement

In the last 12 months, Cerenome had revenue of 5.21M and earned -22.39M in profits. Earnings per share was -7.19.

Revenue
5.21M
Gross Profit
4.77M
Operating Income
-15.30M
Pretax Income
-22.39M
Net Income
-22.39M
EBITDA
-18.33M
Earnings Per Share (EPS)
-7.19

Cash Flow

In the last 12 months, operating cash flow was -27.30M and capital expenditures -1.40M, giving a free cash flow of -28.70M billion.

Operating Cash Flow
-27.30M
Free Cash Flow
-28.70M
Free Cash Flow per Share
-3.79

Dividends & Yields

Cerenome pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-591.02%
Earnings Yield
-626.33%

Stock Price Statistics

Beta
1.14
52-Week Price Change
-97.42%
50-Day Moving Average
1.46
200-Day Moving Average
9.71
Relative Strength Index (RSI)
35.52
Average Volume (3m)
590

Important Dates

Cerenome upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 13, 2026
Next Earnings Date
Feb 25, 2027
Ex-Dividend Date
―

Financial Position

Cerenome as a current ratio of 1.23, with Debt / Equity ratio of 20.55%

Current Ratio
1.23
Quick Ratio
1.23
Debt to Market Cap
0.07
Net Debt to EBITDA
0.43
Interest Coverage Ratio
-4.24

Taxes

In the past 12 months, Cerenome has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Cerenome EV to EBITDA ratio is -0.31, with an EV/FCF ratio of -0.28.

EV to Sales
2.26
EV to EBITDA
-0.31
EV to Free Cash Flow
-0.28
EV to Operating Cash Flow
-0.29

Balance Sheet

Cerenome has EUR 4.87M in cash and marketable securities with EUR 3.98M in debt, giving a net cash position of EUR 890.00K billion.

Cash & Marketable Securities
EUR 4.87M
Total Debt
EUR 3.98M
Net Cash
EUR 890.00K
Net Cash Per Share
EUR 0.09
Tangible Book Value Per Share
-EUR 0.20

Margins

Gross margin is 59.67%, with operating margin of -832.57%, and net profit margin of -859.47%.

Gross Margin
59.67%
Operating Margin
-832.57%
Pretax Margin
-859.47%
Net Profit Margin
-859.47%
EBITDA Margin
-717.52%
EBIT Margin
-732.00%

Analyst Forecast

The average price target for Cerenome is EUR 21.15, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 21.15
Price Target Upside
2816.83% Upside
Analyst Consensus
Strong Buy
Analyst Count
4
Revenue Growth Forecast
-36.15%
EPS Growth Forecast
91.19%